MSF - Ramadan Campaign
Choithrams and Medecins Sans Frontieres bring hope to more than 20,000 women in Malawi this Ramadan
Choithrams supports 1999 Nobel Peace Prize Laureate Medecins Sans Frontieres (MSF)’s efforts to bring comprehensive medical care to thousands of cervical cancer patients in Malawi. The collaboration will provide much-needed relief for many women suffering from cancer in the Southern African country by providing timely intervention to a disease that is preventable, detectable, and treatable in the early stage.
Learn more about the MSF Partnership
The donation from Choithrams will help to improve cervical cancer screening, and provide patients with access to diagnosis and treatment through Queen Elizabeth Central Hospital, a public healthcare facility supported by MSF and serving Malawi’s populous Blantyre and Chiradzulu districts.
Expanding on the remit of the support, Mario Stephan Executive Director of MSF UAE shared, “The Cervical cancer project aims to provide comprehensive cervical cancer services in close collaboration with the Ministry of Health (MoH). The project will focus on comprehensive continuity of care-approach by rolling out a spectrum of patient-centered cervical cancer activities in the area of primary, secondary and tertiary prevention and treatment.”
Choithrams Supports MSF Bring Hope More 20000 Women Malawi Ramadan
MSF partnership over the years
Choithrams shares a special relation with Médecins Sans Frontières (MSF), also known as Doctors Without Borders.
Our journey with MSF started in the early 1990s when we supported medical interventions in West Africa. Emphasizing the need for spreading goodness, in 2003, we joined forces with MSF to create a refugee camp in the heart of Global Village in Dubai. The objective was to spread awareness of the vulnerable conditions thousands face every day in disaster-affected zones. Since then, we have been actively supporting pathbreaking MSF projects in the region.
Antibiogo - 2
Take this critical challenge: what happens when drugs stop responding, when bacteria develops resistance to antibiotics which are used for treatment. Antibiotic resistance is a major public health challenge that MSF is taking head on. By supporting MSF’s Antibiotic Stewardship Programme in Amman, we are able heal the wounds of war, and to treat patients from Iraq, Syria, Palestine, and Yemen for the past 14 years. Without this hospital, patients would not have access to the medical care needed for their complex injuries.
The World Health Organization estimates more than 10 million people will be affected by drug-resistant diseases each year by 2050. That is why we are hopeful that the advances made by using artificial intelligence to power MSF’s app Antibiogo will make a significant difference to millions of lives. With our ongoing support, the innovative app will combat the spread of antimicrobial resistance, it is specially relevant in low-resource settings where access to correct diagnosis of bacterial diseases is not generally available.
